Rifaximin Resistance in Escherichia coli Associated with Inflammatory Bowel Disease Correlates with Prior Rifaximin Use, Mutations in rpoB, and Activity of Phe-Arg-β-Naphthylamide-Inhibitable Efflux Pumps.
Antimicrobial Agents and Chemotherapy.
Times cited: 31
Multidrug resistance is common in Escherichia coli associated with ileal Crohn's disease.
Inflammatory Bowel Diseases.
Times cited: 17